相似文献
1
Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome.
Ann Rheum Dis. 2003 Nov;62(11):1038-46. doi: 10.1136/ard.62.11.1038.
2
Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome.
Ann Rheum Dis. 2006 Feb;65(2):195-200. doi: 10.1136/ard.2005.038232. Epub 2005 Jun 23.
3
Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren's syndrome.
Hum Gene Ther. 2003 Nov 20;14(17):1605-18. doi: 10.1089/104303403322542257.
4
Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjögren's syndrome.
Arthritis Res Ther. 2009;11(6):R189. doi: 10.1186/ar2888. Epub 2009 Dec 14.
5
Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome.
Arthritis Res Ther. 2012 Feb 27;14(1):R40. doi: 10.1186/ar3753.
6
TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice.
Oral Dis. 2012 May;18(4):365-74. doi: 10.1111/j.1601-0825.2011.01885.x. Epub 2011 Dec 29.
7
Human umbilical cord mesenchymal stem cells confer potent immunosuppressive effects in Sjögren's syndrome by inducing regulatory T cells.
Mod Rheumatol. 2021 Jan;31(1):186-196. doi: 10.1080/14397595.2019.1707996. Epub 2020 Jan 7.
8
Neutralizing antibodies against adeno-associated viruses in Sjögren's patients: implications for gene therapy.
Gene Ther. 2017 Apr;24(4):241-244. doi: 10.1038/gt.2017.1. Epub 2017 Feb 2.
9
Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy.
Arthritis Res Ther. 2012 Jul 24;14(4):R172. doi: 10.1186/ar3925.
10
Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice.
Oncotarget. 2017 Apr 18;8(16):27240-27251. doi: 10.18632/oncotarget.15916.
引用本文的文献
1
Effect of soluble ICAM-1 on a Sjögren's syndrome-like phenotype in NOD mice is disease stage dependent.
PLoS One. 2011 May 12;6(5):e19962. doi: 10.1371/journal.pone.0019962.
2
Gene therapy of the rheumatic diseases: 1998 to 2008.
Arthritis Res Ther. 2009;11(1):209. doi: 10.1186/ar2563. Epub 2009 Jan 30.
3
Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment.
Ann Rheum Dis. 2006 Nov;65(11):1406-13. doi: 10.1136/ard.2006.052761. Epub 2006 Jul 31.
4
Treatment of human disease by adeno-associated viral gene transfer.
Hum Genet. 2006 Jul;119(6):571-603. doi: 10.1007/s00439-006-0165-6. Epub 2006 Apr 13.
5
Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjogren's syndrome.
Ann Rheum Dis. 2006 Feb;65(2):195-200. doi: 10.1136/ard.2005.038232. Epub 2005 Jun 23.
本文引用的文献
1
SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES.
Medicine (Baltimore). 1965 May;44:187-231.
2
Apoptosis and apoptosis-related molecules in the submandibular gland of the nonobese diabetic mouse model for Sjögren's syndrome: limited role for apoptosis in the development of sialoadenitis.
Lab Invest. 2003 Jan;83(1):3-11. doi: 10.1097/01.lab.0000048721.21475.d1.
3
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency.
N Engl J Med. 2003 Jan 16;348(3):255-6. doi: 10.1056/NEJM200301163480314.
4
The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome.
Ann Rheum Dis. 2003 Feb;62(2):168-71. doi: 10.1136/ard.62.2.168.
5
Gene transfer mediated by different viral vectors following direct cannulation of mouse submandibular salivary glands.
Eur J Oral Sci. 2002 Jun;110(3):254-60. doi: 10.1034/j.1600-0722.2002.21200.x.
6
The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome.
Clin Exp Immunol. 2002 Jun;128(3):562-8. doi: 10.1046/j.1365-2249.2002.01869.x.
7
Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome.
Arthritis Rheum. 2002 Mar;46(3):741-7. doi: 10.1002/art.10221.
8
Gene transfer to salivary glands.
Int Rev Cytol. 2002;213:93-146. doi: 10.1016/s0074-7696(02)13013-0.
9
Recombinant adeno-associated virus serotype 2 vectors mediate stable interleukin 10 secretion from salivary glands into the bloodstream.
Hum Gene Ther. 2002 Jan 20;13(2):287-98. doi: 10.1089/10430340252769806.
10
Gene therapy in rheumatic diseases.
Best Pract Res Clin Rheumatol. 2001 Dec;15(5):771-88. doi: 10.1053/berh.2001.0193.
Zotero 插件